I believe any deal with some other company would launch Emis to a whole different level. And of course having Eligen B12 as additional validation doesn't hurt; although its impact right now is minor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.